Postoperative pain control after breast surgery

Transdermal fentanyl patch as an adjuvant to paravertebral block for pain control after breast cancer surgery : a randomized double blind controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN76105318

Enrollment

Registered

2016-06-30

Start date

2016-03-22

Completion date

Unknown

Last updated

2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain (breast cancer patients) Cancer

Interventions

Patients will be randomly classified using sealed envelope into two equal groups each of 25 patients. 1. Group A: (TDF & PVB) Patients of this group will obtain a tran

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Female with cancer breast with physical status ASA 1-3 scheduled for cancer breast surgery

Exclusion criteria

Exclusion criteria: Patients with: 1. Central neuropathy 2. Coagulopathy 3. Psychiatric illness 4. History of drug abuse 5. Liver or renal impairment

Design outcomes

Primary

Measure	Time frame
1. The time of the first request for analgesia post surgery 2. Total analgesic consumption in the first 48 hours after surgery	—

Secondary

Measure	Time frame
1. Postoperative adverse effects such as nausea, vomiting, hypotension, bradycardia, and cardiac arrhythmia 2. Postoperative complications of the block including accidental pneumothorax and vascular puncture	—

Countries

Egypt

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026